Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Standing Commission on Liver Disease in the UK

Roger Williams, Graeme Alexander, Iain Armstrong, Alastair Baker, Neeraj Bhala, Ginny Camps-Walsh, Matthew E. Cramp, Simon de Lusignan, Natalie Day, Anil Dhawan, John Dillon, Colin Drummond, Jessica Dyson, Graham Foster, Ian Gilmore, Mark Hudson, Deirdre Kelly, Andrew Langford, Neil McDougall, Petra Meier & 14 others Kieran Moriarty, Philip Newsome, John O'Grady, Rachel Pryke, Liz Rolfe, Peter Rice, Harry Rutter, Nick Sheron, Alison Taylor, Jeremy Thompson, Douglas Thorburn, Julia Verne, John Wass, Andrew Yeoman

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

This report contains new and follow-up metric data relating to the eight main recommendations of the Lancet Standing Commission on Liver Disease in the UK, which aim to reduce the unacceptable harmful consequences of excess alcohol consumption, obesity, and viral hepatitis. For alcohol, we provide data on alcohol dependence, damage to families, and the documented increase in alcohol consumption since removal of the above-inflation alcohol duty escalator. Alcoholic liver disease will shortly overtake ischaemic heart disease with regard to years of working life lost. The rising prevalence of overweight and obesity, affecting more than 60% of adults in the UK, is leading to an increasing liver disease burden. Favourable responses by industry to the UK Government's soft drinks industry levy have been seen, but the government cannot continue to ignore the number of adults being affected by diabetes, hypertension, and liver disease. New direct-acting antiviral drugs for the treatment of chronic hepatitis C virus infection have reduced mortality and the number of patients requiring liver transplantation, but more screening campaigns are needed for identification of infected people in high-risk migrant communities, prisons, and addiction centres. Provision of care continues to be worst in regions with the greatest socioeconomic deprivation, and deficiencies exist in training programmes in hepatology for specialist registrars. Firm guidance is needed for primary care on the use of liver blood tests in detection of early disease and the need for specialist referral. This report also brings together all the evidence on costs to the National Health Service and wider society, in addition to the loss of tax revenue, with alcohol misuse in England and Wales costing £21 billion a year (possibly up to £52 billion) and obesity costing £27 billion a year (treasury estimates are as high as £46 billion). Voluntary restraints by the food and drinks industry have had little effect on disease burden, and concerted regulatory and fiscal action by the UK Government is essential if the scale of the medical problem, with an estimated 63?000 preventable deaths over the next 5 years, is to be addressed.
LanguageEnglish
Pages1097-1107
JournalThe Lancet
Volume391
Issue number10125
DOIs
StatusE-pub ahead of print - 29 Nov 2017

Cite this

Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Standing Commission on Liver Disease in the UK. / Williams, Roger; Alexander, Graeme; Armstrong, Iain; Baker, Alastair; Bhala, Neeraj; Camps-Walsh, Ginny; Cramp, Matthew E.; de Lusignan, Simon; Day, Natalie; Dhawan, Anil; Dillon, John; Drummond, Colin; Dyson, Jessica; Foster, Graham; Gilmore, Ian; Hudson, Mark; Kelly, Deirdre; Langford, Andrew; McDougall, Neil; Meier, Petra; Moriarty, Kieran; Newsome, Philip; O'Grady, John; Pryke, Rachel; Rolfe, Liz; Rice, Peter; Rutter, Harry; Sheron, Nick; Taylor, Alison; Thompson, Jeremy; Thorburn, Douglas; Verne, Julia; Wass, John; Yeoman, Andrew.

In: The Lancet, Vol. 391, No. 10125, 29.11.2017, p. 1097-1107.

Research output: Contribution to journalArticle

Williams, R, Alexander, G, Armstrong, I, Baker, A, Bhala, N, Camps-Walsh, G, Cramp, ME, de Lusignan, S, Day, N, Dhawan, A, Dillon, J, Drummond, C, Dyson, J, Foster, G, Gilmore, I, Hudson, M, Kelly, D, Langford, A, McDougall, N, Meier, P, Moriarty, K, Newsome, P, O'Grady, J, Pryke, R, Rolfe, L, Rice, P, Rutter, H, Sheron, N, Taylor, A, Thompson, J, Thorburn, D, Verne, J, Wass, J & Yeoman, A 2017, 'Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Standing Commission on Liver Disease in the UK', The Lancet, vol. 391, no. 10125, pp. 1097-1107. https://doi.org/10.1016/S0140-6736(17)32866-0
Williams, Roger ; Alexander, Graeme ; Armstrong, Iain ; Baker, Alastair ; Bhala, Neeraj ; Camps-Walsh, Ginny ; Cramp, Matthew E. ; de Lusignan, Simon ; Day, Natalie ; Dhawan, Anil ; Dillon, John ; Drummond, Colin ; Dyson, Jessica ; Foster, Graham ; Gilmore, Ian ; Hudson, Mark ; Kelly, Deirdre ; Langford, Andrew ; McDougall, Neil ; Meier, Petra ; Moriarty, Kieran ; Newsome, Philip ; O'Grady, John ; Pryke, Rachel ; Rolfe, Liz ; Rice, Peter ; Rutter, Harry ; Sheron, Nick ; Taylor, Alison ; Thompson, Jeremy ; Thorburn, Douglas ; Verne, Julia ; Wass, John ; Yeoman, Andrew. / Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Standing Commission on Liver Disease in the UK. In: The Lancet. 2017 ; Vol. 391, No. 10125. pp. 1097-1107.
@article{38589a6df254453699f3ace70202c327,
title = "Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Standing Commission on Liver Disease in the UK",
abstract = "This report contains new and follow-up metric data relating to the eight main recommendations of the Lancet Standing Commission on Liver Disease in the UK, which aim to reduce the unacceptable harmful consequences of excess alcohol consumption, obesity, and viral hepatitis. For alcohol, we provide data on alcohol dependence, damage to families, and the documented increase in alcohol consumption since removal of the above-inflation alcohol duty escalator. Alcoholic liver disease will shortly overtake ischaemic heart disease with regard to years of working life lost. The rising prevalence of overweight and obesity, affecting more than 60{\%} of adults in the UK, is leading to an increasing liver disease burden. Favourable responses by industry to the UK Government's soft drinks industry levy have been seen, but the government cannot continue to ignore the number of adults being affected by diabetes, hypertension, and liver disease. New direct-acting antiviral drugs for the treatment of chronic hepatitis C virus infection have reduced mortality and the number of patients requiring liver transplantation, but more screening campaigns are needed for identification of infected people in high-risk migrant communities, prisons, and addiction centres. Provision of care continues to be worst in regions with the greatest socioeconomic deprivation, and deficiencies exist in training programmes in hepatology for specialist registrars. Firm guidance is needed for primary care on the use of liver blood tests in detection of early disease and the need for specialist referral. This report also brings together all the evidence on costs to the National Health Service and wider society, in addition to the loss of tax revenue, with alcohol misuse in England and Wales costing £21 billion a year (possibly up to £52 billion) and obesity costing £27 billion a year (treasury estimates are as high as £46 billion). Voluntary restraints by the food and drinks industry have had little effect on disease burden, and concerted regulatory and fiscal action by the UK Government is essential if the scale of the medical problem, with an estimated 63?000 preventable deaths over the next 5 years, is to be addressed.",
author = "Roger Williams and Graeme Alexander and Iain Armstrong and Alastair Baker and Neeraj Bhala and Ginny Camps-Walsh and Cramp, {Matthew E.} and {de Lusignan}, Simon and Natalie Day and Anil Dhawan and John Dillon and Colin Drummond and Jessica Dyson and Graham Foster and Ian Gilmore and Mark Hudson and Deirdre Kelly and Andrew Langford and Neil McDougall and Petra Meier and Kieran Moriarty and Philip Newsome and John O'Grady and Rachel Pryke and Liz Rolfe and Peter Rice and Harry Rutter and Nick Sheron and Alison Taylor and Jeremy Thompson and Douglas Thorburn and Julia Verne and John Wass and Andrew Yeoman",
year = "2017",
month = "11",
day = "29",
doi = "10.1016/S0140-6736(17)32866-0",
language = "English",
volume = "391",
pages = "1097--1107",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Masson",
number = "10125",

}

TY - JOUR

T1 - Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Standing Commission on Liver Disease in the UK

AU - Williams, Roger

AU - Alexander, Graeme

AU - Armstrong, Iain

AU - Baker, Alastair

AU - Bhala, Neeraj

AU - Camps-Walsh, Ginny

AU - Cramp, Matthew E.

AU - de Lusignan, Simon

AU - Day, Natalie

AU - Dhawan, Anil

AU - Dillon, John

AU - Drummond, Colin

AU - Dyson, Jessica

AU - Foster, Graham

AU - Gilmore, Ian

AU - Hudson, Mark

AU - Kelly, Deirdre

AU - Langford, Andrew

AU - McDougall, Neil

AU - Meier, Petra

AU - Moriarty, Kieran

AU - Newsome, Philip

AU - O'Grady, John

AU - Pryke, Rachel

AU - Rolfe, Liz

AU - Rice, Peter

AU - Rutter, Harry

AU - Sheron, Nick

AU - Taylor, Alison

AU - Thompson, Jeremy

AU - Thorburn, Douglas

AU - Verne, Julia

AU - Wass, John

AU - Yeoman, Andrew

PY - 2017/11/29

Y1 - 2017/11/29

N2 - This report contains new and follow-up metric data relating to the eight main recommendations of the Lancet Standing Commission on Liver Disease in the UK, which aim to reduce the unacceptable harmful consequences of excess alcohol consumption, obesity, and viral hepatitis. For alcohol, we provide data on alcohol dependence, damage to families, and the documented increase in alcohol consumption since removal of the above-inflation alcohol duty escalator. Alcoholic liver disease will shortly overtake ischaemic heart disease with regard to years of working life lost. The rising prevalence of overweight and obesity, affecting more than 60% of adults in the UK, is leading to an increasing liver disease burden. Favourable responses by industry to the UK Government's soft drinks industry levy have been seen, but the government cannot continue to ignore the number of adults being affected by diabetes, hypertension, and liver disease. New direct-acting antiviral drugs for the treatment of chronic hepatitis C virus infection have reduced mortality and the number of patients requiring liver transplantation, but more screening campaigns are needed for identification of infected people in high-risk migrant communities, prisons, and addiction centres. Provision of care continues to be worst in regions with the greatest socioeconomic deprivation, and deficiencies exist in training programmes in hepatology for specialist registrars. Firm guidance is needed for primary care on the use of liver blood tests in detection of early disease and the need for specialist referral. This report also brings together all the evidence on costs to the National Health Service and wider society, in addition to the loss of tax revenue, with alcohol misuse in England and Wales costing £21 billion a year (possibly up to £52 billion) and obesity costing £27 billion a year (treasury estimates are as high as £46 billion). Voluntary restraints by the food and drinks industry have had little effect on disease burden, and concerted regulatory and fiscal action by the UK Government is essential if the scale of the medical problem, with an estimated 63?000 preventable deaths over the next 5 years, is to be addressed.

AB - This report contains new and follow-up metric data relating to the eight main recommendations of the Lancet Standing Commission on Liver Disease in the UK, which aim to reduce the unacceptable harmful consequences of excess alcohol consumption, obesity, and viral hepatitis. For alcohol, we provide data on alcohol dependence, damage to families, and the documented increase in alcohol consumption since removal of the above-inflation alcohol duty escalator. Alcoholic liver disease will shortly overtake ischaemic heart disease with regard to years of working life lost. The rising prevalence of overweight and obesity, affecting more than 60% of adults in the UK, is leading to an increasing liver disease burden. Favourable responses by industry to the UK Government's soft drinks industry levy have been seen, but the government cannot continue to ignore the number of adults being affected by diabetes, hypertension, and liver disease. New direct-acting antiviral drugs for the treatment of chronic hepatitis C virus infection have reduced mortality and the number of patients requiring liver transplantation, but more screening campaigns are needed for identification of infected people in high-risk migrant communities, prisons, and addiction centres. Provision of care continues to be worst in regions with the greatest socioeconomic deprivation, and deficiencies exist in training programmes in hepatology for specialist registrars. Firm guidance is needed for primary care on the use of liver blood tests in detection of early disease and the need for specialist referral. This report also brings together all the evidence on costs to the National Health Service and wider society, in addition to the loss of tax revenue, with alcohol misuse in England and Wales costing £21 billion a year (possibly up to £52 billion) and obesity costing £27 billion a year (treasury estimates are as high as £46 billion). Voluntary restraints by the food and drinks industry have had little effect on disease burden, and concerted regulatory and fiscal action by the UK Government is essential if the scale of the medical problem, with an estimated 63?000 preventable deaths over the next 5 years, is to be addressed.

U2 - 10.1016/S0140-6736(17)32866-0

DO - 10.1016/S0140-6736(17)32866-0

M3 - Article

VL - 391

SP - 1097

EP - 1107

JO - The Lancet

T2 - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 10125

ER -